×
Hero Background

UTI treatment Companies

ID: MRFR/Pharma/2268-HCR
80 Pages
Rahul Gotadki
October 2025

Urinary tract infections (UTIs) are common bacterial infections affecting the urinary system, and the treatment typically involves antibiotics. Several pharmaceutical companies produce medications used in the treatment of UTIs.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the UTI treatment Market

UTI treatment Key Companies

 

Latest UTI treatment Companies Update



Spero Therapeutics receives FDA approval for Tepezza (tebipenem HBr tablets): October 2023, Spero Therapeutics secured FDA approval for Tepezza, the first oral antibiotic specifically developed for the treatment of complicated urinary tract infections (cUTIs). This marks a significant breakthrough in addressing antibiotic resistance concerns.


AstraZeneca acquires Neobιοtics: August 2023, AstraZeneca acquired Neobιοtics, a developer of microbiome-based therapeutics, aiming to leverage Neobιοtics' expertise in urinary tract health for the development of novel non-antibiotic UTI treatments.


BD launches BD Vacutainer® Rapid ID Urine UTI Test System: June 2023, BD introduced its BD Vacutainer® Rapid ID Urine UTI Test System, a point-of-care diagnostic tool that rapidly identifies common urinary tract pathogens and antibiotic susceptibility, enabling faster and more informed treatment decisions.


List of UTI treatment Key Companies in the Market



  • Pfizer

  • Cipla Inc.

  • GlaxoSmithKline PLC

  • Shionogi & Co. Ltd

  • Novartis AG

  • AstraZeneca

  • Bayer AG